Danaher | DHR - Interest Expense On Debt


Danaher reported $135M in Interest Expense on Debt for its fiscal quarter ending in September of 2026.





Interest Expense On Debt Change Date
Abbott USD 297M 2M Sep/2026
Agilent USD 29M 4M Jun/2026
Align Technology USD 9.96M 3.02M Jun/2026
Becton, Dickinson and Co. USD 130M 2M Sep/2026
Bio Techne USD 2.17M 1.43M Sep/2026
Bio-Rad Laboratories USD 12.1M 200K Jun/2026
Boston Scientific USD 100M 4M Sep/2026
Bruker USD 17.8M 9.7M Jun/2026
Charles River Laboratories USD 28.52M 1.82M Sep/2026
Danaher USD 135M 28M Sep/2026
Dentsply International USD 27M 5M Sep/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
ESCO Technologies USD 8.71M 6.31M Jun/2026
Fortive USD 38.8M 3.4M Sep/2026
Henry Schein USD 42M 1000K Sep/2026
Illumina USD 24M 0 Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
IQVIA Holdings USD 203M 6M Sep/2026
Keysight Technologies USD 26M 1000K Jun/2026
Laboratory Of America USD 59.1M 2M Sep/2026
Medtronic USD 186M 10M Jun/2026
Mettler Toledo International USD 15.68M 1.57M Sep/2026
Myriad Genetics USD 4.4M 600K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Quest Diagnostics USD 61M 8M Sep/2026
Quidel USD 5.78B 66M Sep/2026
Repligen USD 5.71M 49K Sep/2026
Revvity USD 20.81M 2.18M Sep/2026
Roper Industries USD 93.3M 3.6M Dec/2025
Stryker USD 47.25B 683M Sep/2026
Thermo Fisher Scientific USD 417M 63M Sep/2026
Waters USD 53M 2M Sep/2026
Zimmer Biomet Holdings USD 23.54B 740.8M Sep/2026